HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wan-Long Chuang Selected Research

Inflammation (Inflammations)

10/2021First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients.
12/2012High therapeutic concentration of prazosin up-regulates angiogenic IL6 and CCL2 genes in hepatocellular carcinoma cells.
7/2011Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wan-Long Chuang Research Topics

Disease

121Chronic Hepatitis C
11/2022 - 01/2002
112Infections
03/2024 - 01/2002
65Fibrosis (Cirrhosis)
04/2024 - 03/2002
64Hepatocellular Carcinoma (Hepatoma)
03/2024 - 09/2004
47Chronic Hepatitis B
03/2024 - 02/2006
35Neoplasms (Cancer)
03/2024 - 02/2002
26Liver Cirrhosis (Hepatic Cirrhosis)
02/2024 - 03/2002
24Hepatitis C
01/2024 - 02/2006
23Hepatitis B
09/2023 - 02/2009
15Liver Diseases (Liver Disease)
05/2024 - 01/2007
14Viremia
12/2021 - 01/2002
12Hepatitis
02/2024 - 06/2007
8Insulin Resistance
05/2015 - 04/2009
7Body Weight (Weight, Body)
04/2024 - 02/2006
7Non-alcoholic Fatty Liver Disease
04/2024 - 03/2016
7Fatty Liver
10/2023 - 12/2007
7Hypertension (High Blood Pressure)
10/2023 - 12/2007
6Coinfection
10/2023 - 10/2004
6Chronic Renal Insufficiency
02/2022 - 07/2020
5Virus Diseases (Viral Diseases)
02/2022 - 07/2003
5Disease Progression
01/2021 - 04/2008
4Liver Neoplasms (Liver Cancer)
10/2023 - 07/2013
4Headache (Headaches)
11/2022 - 07/2016
4Diabetes Mellitus
01/2022 - 09/2012
4Chronic Kidney Failure (Chronic Renal Failure)
08/2021 - 01/2016
3COVID-19
02/2024 - 09/2022
3Inflammation (Inflammations)
10/2021 - 07/2011
3HIV Infections (HIV Infection)
07/2020 - 01/2014
3Hemorrhage
07/2020 - 11/2002
3Respiratory Tract Infections (Respiratory Tract Infection)
01/2020 - 11/2016
3Nasopharyngitis
01/2020 - 11/2016
3Type 2 Diabetes Mellitus (MODY)
05/2015 - 02/2008
3End Stage Liver Disease
03/2009 - 12/2006

Drug/Important Bio-Agent (IBA)

62Ribavirin (Virazole)FDA LinkGeneric
10/2023 - 10/2004
61Antiviral Agents (Antivirals)IBA
03/2024 - 04/2008
53InterferonsIBA
06/2023 - 07/2003
35RNA (Ribonucleic Acid)IBA
01/2022 - 01/2002
21Hepatitis B Surface Antigens (HBsAg)FDA Link
11/2023 - 06/2007
19Alanine Transaminase (SGPT)IBA
02/2024 - 01/2002
19Interferon-alpha (Interferon Alfa)IBA
04/2021 - 01/2002
17DNA (Deoxyribonucleic Acid)IBA
02/2024 - 01/2002
16Hepatitis B e AntigensIBA
03/2024 - 09/2007
13Tenofovir (Viread)FDA Link
03/2024 - 01/2016
11entecavirFDA Link
03/2024 - 01/2014
11Proteins (Proteins, Gene)FDA Link
10/2023 - 05/2011
10Biomarkers (Surrogate Marker)IBA
01/2024 - 08/2010
10Glucose (Dextrose)FDA LinkGeneric
09/2022 - 12/2007
9Triglycerides (Triacylglycerol)IBA
01/2021 - 07/2006
8tenofovir alafenamideIBA
02/2024 - 11/2016
8SofosbuvirIBA
01/2024 - 01/2016
8Lamivudine (Epivir)FDA Link
11/2016 - 12/2006
7Sorafenib (BAY 43-9006)FDA Link
09/2022 - 02/2017
7Uric Acid (Urate)IBA
03/2020 - 09/2008
7peginterferon alfa-2a (Pegasys)FDA Link
07/2018 - 02/2009
6nasIBA
04/2024 - 01/2014
6NucleotidesIBA
10/2023 - 01/2014
6ColchicineFDA LinkGeneric
10/2023 - 09/2013
6sofosbuvir drug combination ledipasvirIBA
08/2022 - 07/2016
6daclatasvirIBA
01/2021 - 01/2016
5NucleosidesIBA
10/2023 - 01/2014
5BilirubinIBA
01/2022 - 10/2019
5alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2022 - 02/2015
5micaIBA
01/2019 - 12/2015
4Transaminases (Aminotransferases)IBA
04/2024 - 06/2003
4Surface Antigens (Surface Antigen)IBA
11/2023 - 06/2007
4InterleukinsIBA
11/2023 - 01/2013
4AlbuminsIBA
10/2023 - 01/2015
4Aspartate Aminotransferases (Aspartate Transaminase)IBA
09/2022 - 01/2011
4CytokinesIBA
01/2022 - 03/2011
4asunaprevirIBA
01/2021 - 11/2016
4LipidsIBA
11/2020 - 07/2008
4Peptides (Polypeptides)IBA
05/2017 - 10/2010
4CholesterolIBA
05/2015 - 07/2008
3MicroRNAs (MicroRNA)IBA
03/2024 - 05/2014
3glecaprevir and pibrentasvirIBA
01/2024 - 01/2018
3Hemoglobins (Hemoglobin)IBA
01/2024 - 04/2017
3Carrier Proteins (Binding Protein)IBA
03/2022 - 08/2017
3wisteria lectinIBA
03/2022 - 08/2017
3ChemokinesIBA
01/2022 - 05/2010
3C-Reactive ProteinIBA
11/2021 - 03/2002
3AntigensIBA
04/2021 - 11/2016
3Indicators and Reagents (Reagents)IBA
01/2021 - 03/2002
3ledipasvirIBA
12/2018 - 01/2017
3Fetal Proteins (Fetoprotein)IBA
03/2018 - 03/2015
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2017 - 06/2003
3Phospholipases (Phospholipase)IBA
03/2016 - 03/2015
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2013 - 09/2004
3Interleukin-6 (Interleukin 6)IBA
06/2013 - 10/2012
3Epirubicin (Ellence)FDA LinkGeneric
12/2011 - 02/2006
2EnzymesIBA
05/2024 - 01/2023
2VaccinesIBA
02/2024 - 03/2009
2velpatasvirIBA
01/2024 - 02/2022
2AntibodiesIBA
11/2023 - 07/2017

Therapy/Procedure

102Therapeutics
02/2024 - 01/2002
7Renal Dialysis (Hemodialysis)
08/2021 - 02/2002
5Aftercare (After-Treatment)
03/2020 - 08/2005
5Liver Transplantation
06/2018 - 01/2007
4Drug Therapy (Chemotherapy)
02/2022 - 02/2006
3Palliative Care (Palliative Therapy)
07/2021 - 05/2015
3Duration of Therapy
06/2020 - 09/2007